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Gene activation can be studied at several levels: transcription (mRNA), translation (proteins), or phenotypical alterations (functional activity or morphol-
ogy). These levels can be studied in situor biochemically by the use of specific probes for normal or altered DNA, mRNA, or proteins. Immunological
probes are potent tools for studies of alterations induced by xenobiotics in target organs. When the effects of xenobiotics are studied in whole tissue,
the cellular heterogeneity of the organ must be taken into account. For this reason, combined in situ and biochemical techniques are necessary.
Antibodies to normal or altered cellular constituents are used for identification, quantitation, and cellular localization of proteins and modified DNA.
Many xenobiotics alter gene activation by interactions with DNA. After activation, 2-acetylaminofluorene (AAF) forms DNA adducts, which can be
identified immunologically. Combined with bromodeoxyuridine (BrdU) pulse labeling, techniques have been developed to demonstrate reduced
adduct concentrations in proliferating cells and preneoplastic foci in the livers of AAF-fed rats. Carcinogen-induced DNA modifications are implicated
as a major mechanism of altered gene activation in neoplasia, leading to phenotypical alterations. Also, cellular differentiation may be affected by
xenobiotics. Differentiation-associated markers can be used for studies of gene activation. In mouse skin, the keratins Kl and K10 are only
expressed in suprabasal, differentiating cells. BrdU pulse chase experiments combined with double immunofluorescence have revealed that Kl and
Kl0 are sequentially turned on 18 to 24 hr after DNA synthesis and are followed by suprabasal migration. After a single application of the tumor pro-
moter 12-Otetradecanoylphorbol-13-acetate (TPA), cell migration starts directly after mitosis. Keratin Kl and K10 were still turned on 18 to 24 hr
after mitosis. The experiments demonstrated that TPA induced accelerated cell migration. Initiation of cell maturation after replication was not
affected by TPA, while transition through the maturation program was significantly accelerated. Gene activation can also be studied with immunologi-
cal probes to the proteins that regulate gene expression, such as growth factor receptors, signal mediators, and transcription factors. It must be kept
in mind that immunological detection reveals the presence of proteins, not their activity. Functional activity may be related to intracellular localization.
The localization of protein kinase C, c-fos, and c-myc proteins, for example, may be altered by their activation. In other cases, activation may be
detected by demonstration of phosphorylation, dimerization, or DNA binding. Western blotting and immunofluorescence have demonstrated
increased expression of the regulatory units of cAMP-dependent protein kinase in rat liver after partial hepatectomy (PH) and when PH is combined
with dietary AAF for growth inhibition. Immunological techniques may be powerful tools for characterization of gene activation. The specificity of the
reagents needs to be extensively controlled under the employed conditions. For studies in whole tissue, immunohistochemical techniques give the
additional opportunity to identify gene activation or expression in subpopulations and individual cells. - Environ Health Perspect 102(Suppl
6):205-207 (1994)
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Gene Activation
Gene activation may lead to mRNA tran-
scription followed by translation into pro-
teins. This process is regulated at different
levels; at the transcriptional level, by post-
transcriptional modifications, at the trans-
lational level, or by protein degradation.
Different signaling pathways regulate these
mechanisms. Xenobiotics may interfere
with these processes at several levels.
Modifications of DNA may alter the regu-
lation or transcription ofgenes or the coding
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sequence. Xenobiotics also may interfere
with the regulatory mechanisms of the
genes and thus cause altered expression.
Immunologicaltechniques can be used for
detection of normal and altered cellular
structures and molecules. Techniques have
been established for quantitation, cellular
or intracellular localization, and molecular
weight characterization of antigens. This
presentation will focus mainly on the use of
immunohistochemical techniques for studies
ofgene activation and altered gene expres-
sion. It must be emphasized, though, that
additional techniques like Western blotting
are required for characterization of anti-
bodies and respective antigens.
DNA Modification
Carcinogens may cause cell alterations by
DNAbinding, which maylead to mutations.
In rat liver, 2-acetylaminofluorene (AAF) is
metabolically activated and forms DNA
adducts. The dominating and carcinogenic
adduct is the deacetylated aminofluorene-
DNA (AF-DNA) adduct. This adduct can
be identified with an antiserum to N-
(deoxyguanosine-8-yl)-2-aminofluorene.
This antiserum has been used for character-
ization ofAAF-DNA modifications during
continuous exposure to 0.025% AAF in the
diet (1). Immunohistochemistry has been
used for in situ localization. Frozen liver
sections were stained by double immuno-
fluorescence to localize AF-DNA adducts
by an indirect FITC-labeled staining
sequence, combined with Texas Red-labeled
indirect immunofluorescence for keratins
in bile ducts. A predominantly periportal
localization of AF-DNA adducts was
revealed (2). Adduct formation can also be
studied in specific subpopulations of cells.
Proliferating cells were pulse labeled with
the thymidine analog 5-bromodeoxyuri-
dine (BrdU) and identified with an anti-
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body to BrdU. Double immunofluorescence
for AF-DNA adducts and BrdU has been
used to demonstrate reduced AF-DNA
adduct staining in replicating liver cells
during continuous AAF exposure, compared
to surrounding tissue (3). In proliferating
foci, which appear after 4 weeks ofAAF
exposure, even lower AF-DNA adduct lev-
els were found. Computerized image analy-
sis was used to quantitate in situ relative
AF-DNA adduct levels in different subpop-
ulations (4). Quantitative immuno-histo-
chemistry may be avaluable tool for studies
of the initial mechanisms ofDNA modifi-
cations altered gene expression during car-
cinogenesis.
Cellular Differentiation
Xenobiotics may alter cell differentiation
either by phenotypical alterations or by
changed differentiation kinetics. This may
be studied with antibodies to specific dif-
ferentiation products. In epidermis, the ter-
minally differentiating keratinocytes
express the keratins Kl and K1O (5). Thus,
these keratins are found in suprabasal epi-
dermis, while the proliferating basal cells
are negative for these keratins (6).
Filaggrin is expressed later during differen-
tiation. This protein is located in the granular
layer of epidermis and participates in the
organization ofkeratin filaments into bun-
dles (7). The differentiation kinetics ofker-
atinocytes can be studied by BrdU pulse
chase experiments. Skin sections from differ-
ent time points following a BrdU injection
were stained bydouble immunofluorescence
for BrdU and either of the differentiation
markers, keratins Kl, KI0, or filaggrin. In
this way, the suprabasal migration and
sequential expression of the BrdU-labeled
cell cohort could be studied (8). In normal
mouse skin, keratin KI was expressed 18
hours after DNAsynthesis, followed by K10
expression and suprabasal migration after
24 hr. After 96 hr, the cells turned on filag-
grin. The effects of 12-0-tetradecanoyl-
phorbol-13-acetate (TPA) on epidermal
differentiation were studied in a similar
experiment (A. Heyden et al., submitted).
Sixteen hours following topical application
ofTPA, BrdU was injected. Skin sections
from different time points following BrdU
labeling revealed that, although suprabasal
migration now started immediately, expres-
sion ofkeratins KI and K10 was not accel-
erated. Filaggrin was expressed at 30 hr
after labeling. These experiments demon-
strated that in TPA-induced hyperplasia
the initiation ofcell differentiation was not
accelerated, while cellular migration and
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Figure 1. Immunoblotting of PKA RIIa expression in livers of young male Fisher rats (weight 200-220 g) at differ-
ent time points following 70% partial hepatectomy. Protein extracts from normal (lane 1) and regenerating liver
(lane 2-11) 2, 4, 8, 12, 16, and 24 hr, 2, 3, 5, and 7 days after partial hepatectomy, respectively, were elec-
trophoresed on an SDS 10% polyacrylamide gel, transferred to nitrocellulose, and detected by ECL (Amersham).
Antiserum to rat Rlla of cAMP-dependent hormone (15), diluted 1:1000 were incubated with the membrane for 18
hrat4°C. Horseradish peroxidase-linked secondary antibody was then added at a dilution of 1:200.
passage through the differentiation pro-
gram was faster than normal.
Oncogenes and Signal
Transducers
Gene expression is regulated bygrowth fac-
tors and other signaling molecules that
bind to cellular receptors (9). Several signal
transduction pathways may then be trig-
gered, activating transcription factors that
regulate mRNA transcription by binding to
DNA. Alterations in the genes ofmany of
these cellular regulators may lead to car-
cinogenic transformation. These genes have
been termed oncogenes. Some growth factors
and receptors are associated with induction
of cell replication, such as epidermal
growth factor receptor, while others may
induce differentiation, such as c-neu (10).
In a similar way, some transcription factors
like c-fos and c-jun are induced during
preparation for DNA replication, while
others are expressed in terminally differen-
tiated cells, such as CCAAT/enhance-bind-
ing protein (11). These proteins may be
detected by immunological probes.
Different strategies may be used to demon-
strate activation ofthese pathways. Ligand
binding and polymerization may be
detected by immunological coprecipitation
techniques. In contrast to most other
enzymes, many ofthe signal receptors and
signal transducers are activated by phos-
phorylation of tyrosine. Antibodies to
phosphotyrosine are therefore often useful
for such studies. Also, many signal trans-
ducers are translocated when activated;
growth factor receptors are internalized
upon ligand binding, and many transcrip-
tion factors are translocated from the cyto-
plasm to the nucleus upon activation (12).
Combined immunochemical and immuno-
histochemical techniques may therefore be
necessary for characterization ofthese regu-
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latory pathways. Cyclic AMP-dependent
protein kinases (PKA) are responsible for
signal transduction ofspecific protein hor-
mones. The regulatory unit RII ofPKA has
been shown to be associated with cellular
differentiation (Figure 1). Activation of
PKA leads to DNA binding of the cAMP-
responsive element binding protein (Figure
2) (13). Studies ofPKA Rlla expression in
the liver have demonstrated induction of
this protein 18 hr after growth induction
by partial hepatectomy. This induction
persisted for 14 days. When partial hepate-
ctomy was performed on rats that were
continuously fed 0.02% AAF, the expres-
sion of Rlla was delayed until 48 hr post-
hepatectomy and diminished after 1 week.
Such modifications in the regulation ofsig-
naling pathways may participate in the
growth inhibitory effects ofAAF.
Conclusion
Immunochemical techniques can be used
to study several aspects of genetic damage
and gene expression: DNA modifications,
cellular differentiation, and signaling path-
ways. Antisera and their antigens need to
be extensively controlled under the
employed conditions. Especially when such
studies are performed in whole tissue, com-
bined immunochemical and immunohisto-
chemical techniques are necessary to
elucidate effects in different cell popula-
tions. Immunohistochemical techniques
give the opportunity to identify gene acti-
vation or expression in subpopulations and
individual cells.
Figure 2. Nuclear staining of cAMP-responsive element binding protein (CREB) by immunofluorescence in normal
rat liver. Frozen sections were acetone fixed, and incubated with anti-CREB antibody (Santa Cruz Biotechnology) at
a 1:30 dilution for 18 hr, followed by fluorescein conjugated antiserum to rabbit immunoglobulins (original magnifica-
tion x 500).
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